Paul Camarata, MD
Neurological Surgery · Kansas City, KSNPI 1558398982
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $890 of the $1,207 with a category attached, or 73.8%. Zimmer Biomet accounts for 87.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $1,153 and has fallen 97.5% since, to $29 in 2025. That places this record below the midpoint for neurological surgery clinicians in KS, where the typical reported total is $1,879.
Across 12 payments — averaging $100.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1K
- Microtransponder, Inc.$93
- GT Medical Technologies, Inc$25
- Globus Medical$15
- Stryker$14
Across 8 payments — averaging $12,509 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sunovion Pharmaceuticals Inc.$100K
What the payments were for
- Travel & lodging$89074%
- Food & beverage$31726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 8 | $1,061 |
| Microtransponder, Inc. | 1 | $93 |
| GT Medical Technologies, Inc | 1 | $25 |
| Globus Medical | 1 | $15 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$820
- Neuro Plating System$132
How this compares
$1,207 in reported general payments places this provider in the 40th percentile of 63 neurological surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 20 | $272 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Kansas City
- Frank HolladayKansas City$349K
- Koji EbersoleKansas City$123K
- Anthony AlvaradoKansas City$80K
- Jeremy PetersonKansas City$28K
- Justin DavisKansas City$24K
- Sarah WoodrowKansas City$21K
- Christopher MillerKansas City$20K
- Ifije OhiorhenuanKansas City$17K
- Michael KinsmanKansas City$12K
- Bailey YekzamanKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.